Anzeige
Mehr »
Donnerstag, 14.08.2025 - Börsentäglich über 12.000 News
Setup für DOGE & LTC Mining läuft an - und diese Aktie steht in der ersten Reihe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
184 Leser
Artikel bewerten:
(1)

Enterprise Imaging IT Market worth US$4.12 Billion by 2030 with 12.2% CAGR | MarketsandMarkets

DELRAY BEACH, Fla., Aug. 14, 2025 /PRNewswire/ -- The global Enterprise Imaging IT Market, valued at US$2.08 billion in 2024, stood at US$2.31 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$4.12 billion by the end of the period. Growth is fueled by the increasing demand for cross-specialty image access in oncology and cardiology, along with the integration of advanced visualization tools like 3D and cinematic rendering into enterprise viewers. The rising adoption of mobile diagnostic imaging and point-of-care ultrasound is also pushing the need for centralized imaging data management. Moreover, the deployment of vendor-neutral archives (VNA) for longitudinal imaging records across networks is driving platform consolidation. However, limited standardization in imaging protocols across departments and high transition costs from legacy systems remain key restraints for market expansion.

MarketsandMarkets Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=259462660

Browse in-depth TOC on "Enterprise Imaging IT Market"

434 - Tables
54 - Figures
411 - Pages

By function, the market is divided into vendor-neutral archives (VNA), picture archiving and communication systems (PACS), image exchange, universal viewer, workflow orchestration, analytics, and other functions. The VNA segment is anticipated to expand at a considerable CAGR throughout the forecast period. The VNA market is propelled by the surge in non-DICOM data such as digital pathology slides, endoscopy videos, and point-of-care ultrasound clips, requiring a truly modality-agnostic repository. New regulations mandating extended retention of imaging for AI training purposes and medico-legal audits are also driving hospitals to replace siloed archives with VNAs that offer scalable, tamper-proof storage. Additionally, the push to integrate imaging into enterprise data lakes for advanced, cross discipline analytics is encouraging providers to invest in VNAs with native API frameworks and cloud bursting capabilities.

By offering, the enterprise imaging IT market is segmented into software and services. In 2024, the software segment held the largest market share of the enterprise imaging IT market globally. The significant market share of this segment can be attributed to the rapid shift toward subscription-based licensing models that lower upfront costs and align software spend with actual imaging volumes. Health systems are also demanding API first, microservices-based architectures that enable plug-and-play integration of imaging modules with EHRs, digital pathology, and genomics platforms. Moreover, vendors embedding real-time BI engines and customizable reporting dashboards directly into their core software are meeting the need for deep, modality-specific performance analytics.

By geography, in 2024, North America held the largest market share for enterprise imaging IT. The large share of this region can be attributed to several factors, including the rapid shift toward image-enabled EHR systems that support real-time clinical decision-making across multi-specialty teams. The growing emphasis on imaging data monetization through research collaborations, AI training datasets, and secondary use licensing is also encouraging investments in robust enterprise imaging infrastructure. Furthermore, the widespread deployment of remote peer review and tumor board solutions across academic medical centers is driving demand for interoperable, enterprise-scale imaging platforms.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=259462660

The prominent players in the enterprise imaging IT market include Agfa-Gevaert Group (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Intelerad (Canada), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), INFINITT Healthcare Co., Ltd. (South Korea), Novarad (US), Mach7 Technologies (US), Hermes Medical Solutions (Sweden), Konica Minolta, Inc. (Japan), BridgeHead Software Ltd. (England), Sclmage, Inc. (US), VISUS Health IT GmbH (Germany), Dicom Systems, Inc. (US), PostDICOM (Netherlands), Qaelum (Belgium), AdvaHealth Solutions (Singapore), PaxeraHealth (US), and Rad AI (US).

Agfa-Gevaert Group (Belgium)

Agfa-Gevaert Group develops, produces, and distributes an extensive range of analog and digital imaging solutions, mainly for the healthcare sector and printing industry. The company operates through three business segments: Digital Print & Chemicals, HealthCare IT, and Radiology Solutions. Through its HealthCare IT division, the company delivers advanced imaging informatics solutions that support hospitals and healthcare networks in their digital transformation. Its enterprise imaging platform integrates radiology, cardiology, and other departmental imaging workflows into a unified system, enabling seamless image access, sharing, and collaboration across care teams. Agfa-Gevaert's offerings cater to a wide range of end users, including large hospital networks, academic medical centers, diagnostic imaging centers, and specialty clinics. Agfa HealthCare operates through a strong international network, with wholly owned sales organizations in over 40 countries and additional representation via agents and distributors across nearly 100 others. Its main enterprise imaging hubs and R&D/manufacturing sites are in Belgium, the US, Canada, Germany, China, Brazil, and other strategic regions, complemented by regional offices in key markets such as the Middle East and South Africa.

GE HealthCare (US)

GE HealthCare develops, manufactures, and markets a broad portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The company has a large, global installed base of medical imaging, ultrasound, and patient monitoring systems. GE HealthCare operates mainly through four divisions: Imaging, Advanced Visualizing Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. On March 31, 2020, the company completed the sale of its Biopharma business segment to Danaher Corporation for USD 20,718 million. The company provides IT solutions, including enterprise and departmental information technology products, picture archiving systems (PACS), radiology information systems (RIS), cardiovascular information systems (CVIS), and practice applications. The main end users of the company's solutions include hospitals, pharmaceutical firms, biotechnology companies, medical facilities, and life science research bodies. GE HealthCare serves customers in over 160 countries, conducts R&D in 18 countries, and manufactures its products in 20 countries worldwide. The company has a geographical presence in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

For more information, Inquire Now!

Related Reports:

Diagnostic Imaging Market

MRI Systems Market

Healthcare IT Market

Remote Patient Monitoring (RPM) Market

IoT Medical Devices Market

Get access to the latest updates on Enterprise Imaging Companies and Enterprise Imaging Market Size

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/enterprise-imaging-it-market-worth-us4-12-billion-by-2030-with-12-2-cagr--marketsandmarkets-302529836.html

© 2025 PR Newswire
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.